Eli Lilly and (LLY)
826.57
4.06 (0.49%)
At close: Mar 31, 2025, 3:59 PM
832.66
0.74%
Pre-market: Apr 01, 2025, 04:35 AM EDT
Neuroscience Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 351.8M | -37.3M | -9.59% |
| Mar 31, 2024 | 389.1M | -1.38B | -77.99% |
| Sep 30, 2023 | 1.77B | 1.38B | +356.64% |
| Jun 30, 2023 | 387.2M | 26.7M | +7.41% |
| Mar 31, 2023 | 360.5M | -12.7M | -3.40% |
| Sep 30, 2022 | 373.2M | -16.7M | -4.28% |
| Jun 30, 2022 | 389.9M | -7.8M | -1.96% |
| Mar 31, 2022 | 397.7M | -52.5M | -11.66% |
| Sep 30, 2021 | 450.2M | -62M | -12.10% |
| Jun 30, 2021 | 512.2M | 46.8M | +10.06% |
| Mar 31, 2021 | 465.4M | -5.3M | -1.13% |
| Sep 30, 2020 | 470.7M | 48.2M | +11.41% |
| Jun 30, 2020 | 422.5M | -41M | -8.85% |
| Mar 31, 2020 | 463.5M | 36.8M | +8.62% |
| Sep 30, 2019 | 426.7M | -26M | -5.74% |
| Jun 30, 2019 | 452.7M | 59.6M | +15.16% |
| Mar 31, 2019 | 393.1M | -250.6M | -38.93% |
| Mar 31, 2016 | 643.7M | -78M | -10.81% |
| Dec 31, 2015 | 721.7M | -2.8M | -0.39% |
| Sep 30, 2015 | 724.5M | -39.4M | -5.16% |
| Jun 30, 2015 | 763.9M | 38.6M | +5.32% |
| Mar 31, 2015 | 725.3M | -143.2M | -16.49% |
| Dec 31, 2014 | 868.5M | -13.9M | -1.58% |
| Sep 30, 2014 | 882.4M | 24M | +2.80% |
| Jun 30, 2014 | 858.4M | 94.1M | +12.31% |
| Mar 31, 2014 | 764.3M | -110.1M | -12.59% |
| Dec 31, 2013 | 874.4M | 52.6M | +6.40% |
| Sep 30, 2013 | 821.8M | 13.7M | +1.70% |
| Jun 30, 2013 | 808.1M | 43.9M | +5.74% |
| Mar 31, 2013 | 764.2M | -75M | -8.94% |
| Dec 31, 2012 | 839.2M | 47.5M | +6.00% |
| Sep 30, 2012 | 791.7M | -55.1M | -6.51% |
| Jun 30, 2012 | 846.8M | 42.9M | +5.34% |
| Mar 31, 2012 | 803.9M | -21.9M | -2.65% |
| Jun 30, 2011 | 825.8M | -1.58B | -65.66% |
| Mar 31, 2011 | 2.41B | n/a | n/a |